Discovery of SHR1127, an Orally Bioavailable, Highly Potent and Selective KRAS G12D Inhibitor
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined